MedBetterHealth CEO steers BioFlorida panel spotlighting Florida’s hidden biotech founders

written by Samuel Reed · 5 days ago
MedBetterHealth CEO steers BioFlorida panel spotlighting Florida’s hidden biotech founders

What happens when a dementia-care physician steps off the clinical floor and onto a conference stage? At BioFlorida’s 29th Annual Florida Innovation Conference, the answer was a sharp focus on the founders most audiences have never heard of. Dr. Erik Ilyayev, Founder and CEO of MedBetterHealth—a physician-led dementia care organization based in Davie, Florida—moderated the Innovation Spotlight panel on October 15, 2026, at the JW Marriott Orlando Grande Lakes, where nearly a thousand leaders from across Florida’s life sciences community convened.

Dr. Erik Ilyayev discusses the innovation in biotech and neuroscience on October 15, 2026 Innovation Spotlight panel in Orlando.

BioFlorida President Mark Glickman personally tapped Dr. Ilyayev to lead the session, which was designed to highlight Florida founders whose companies have not yet registered on the radar of many statewide audiences. The panel included:

Also worth a look: Houston Area Urban League lands Texas’ only USDA market grant for Third Ward food access and Salt Lake City surgeon Steven Mobley teaches male eyelid surgery as demand surges among men who want to look rested, not ‘done.

• Dan Salain, President and CEO of Recall Therapeutics (Naples), which is developing gene therapy for Alzheimer’s disease
• Jackie von Salm, PhD, Cofounder and Chief Science Officer of Psilera (Tampa), which is developing non-hallucinogenic molecules derived from psychedelics, including a program for frontotemporal dementia
• Tom Christensen, KIFFIK Biomedical (Miami), which is developing needle-free access to interstitial fluid for real-time diagnostics

Rather than diving into technical jargon, the conversation traced each founder’s personal journey. Panelists opened up about the healthcare challenge that motivated them to launch their companies, what sets their approach apart from existing solutions, and the real work required to move from concept to commercial reality. The discussion also tackled Florida’s funding landscape and offered practical advice for founders in the audience who are navigating similar paths.

“Every day at MedBetterHealth, families living with dementia ask us what is coming next,” said Dr. Ilyayev. “On that stage, I heard real answers being built right here in Florida. Dan, Jackie, and Tom showed what it takes to turn bold science into something that can reach patients. BioFlorida, under Mark Glickman’s leadership, gave them the platform to tell that story.”

About MedBetterHealth

MedBetterHealth is a physician-led dementia care organization headquartered in Davie, Florida. The practice delivers dementia care, care navigation, and caregiver support to patients and families across South Florida, including through the CMS GUIDE Model. More information is available at MedBetterHealth.org.

Dr. Erik Ilyayev
MedBetterHealth
+1 305-339-1756
Dr.Erik@MedBetterHealth.org

Why it matters

This panel underscores how Florida is quietly becoming a proving ground for dementia and neuroscience innovation, with founders moving from concept to patients. For the thousands of families navigating Alzheimer’s and related conditions, these emerging companies may represent the next wave of real-world treatments—and the conversation shows that the state’s life-sciences community is actively working to shorten the distance between lab bench and bedside.


Samuel Reed

Samuel Reed

Samuel Reed is a senior journalist covering the intersection of business, technology, and society. With over a decade of experience, his work focuses on artificial intelligence, corporate governance, and emerging tech trends.

You May Also Like